DRG Market Assessment reports
Access comprehensive market intelligence covering Disease Landscape & Forecast, Epidemiology Intelligence, Biosimilars Intelligence, China In-depth and more.
Renal Cell Carcinoma – Landscape & Forecast – Disease Landscape & Forecast (G7)
The renal cell carcinoma (RCC) therapy market spans multiple drug classes. Immune checkpoint inhibitor-based combinations continue to anchor first-line treatment, with regimens such as Opdivo plus…
Psoriatic Arthritis – Landscape & Forecast – Disease Landscape & Forecast (Major Markets)
The psoriatic arthritis (PsA) treatment market is experiencing significant shifts with the introduction of newer targeted therapies, such as AbbVie’s Rinvoq and Skyrizi, and UCB’s Bimzelx…
Squamous Cell Carcinoma of the Head and Neck – Landscape & Forecast – Disease Landscape & Forecast (Major Markets)
Squamous cell carcinoma of the head and neck (SCCHN) is the seventh most commonly diagnosed cancer. It encompasses a spectrum of heterogeneous tumors originating at multiple sites in the head and…
Non-Small-Cell Lung Cancer – Landscape & Forecast – Disease Landscape & Forecast (G7)
The multibillion-dollar NSCLC therapy market is highly dynamic, with more than 40 targeted drugs approved, but still a high unmet need. Immune checkpoint inhibitors such as Keytruda (Merck & Co.)…
Acute Myeloid Leukemia – Landscape & Forecast – Disease Landscape & Forecast (Major Markets)
Although chemotherapy has long anchored acute myeloid leukemia (AML) treatment, the landscape is rapidly evolving with the approval of targeted agents. The 2025 FDA approvals of the menin…
Age-Related Macular Degeneration – Landscape & Forecast – Disease Landscape & Forecast (Major Markets)
AMD is a leading cause of vision loss across the major markets, with wet AMD accounting for most drug-treated cases. The wet AMD market is dominated by IVT anti-VEGF or anti-VEGF / Ang-2 therapies…
Metabolic Dysfunction-Associated Steatohepatitis – Landscape & Forecast – Disease Landscape & Forecast (G7)
The metabolic dysfunction–associated steatohepatitis (MASH) market presents substantial untapped potential, driven by high disease prevalence and limited number of approved treatment options…
B-Cell Non-Hodgkin Lymphoma – Landscape & Forecast – Disease Landscape & Forecast (Major Markets)
The B-cell non-Hodgkin lymphoma (B-cell NHL) therapy market is rapidly growing as newer agents provide alternatives to conventional chemoimmunotherapy regimens. This report focuses on the most…